Rimadyl Palatable Tablets for Dogs 50 mg

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Carprofen

Disponible desde:

Zoetis UK Limited

Código ATC:

QM01AE91

Designación común internacional (DCI):

Carprofen

formulario farmacéutico:

Tablet

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Dogs

Área terapéutica:

Anti Inflammatory NSAID

Estado de Autorización:

Authorized

Fecha de autorización:

2003-02-14

Ficha técnica

Revised: April 2020
AN:01995/2019
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rimadyl Palatable Tablets for dogs 50 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50mg Carprofen.
For the full list of all other excipients see section 6.1
3.
PHARMACEUTICAL FORM
Tablet.
A light brown square tablet with “R” engraved on one side and
bisected
on the other side.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For analgesia and reduction of chronic inflammation, for example in
degenerative joint disease in the dog.
The tablets can also be used in the management of post-operative pain.
4.3
CONTRAINDICATIONS
Do not exceed the stated dose.
The elimination time of NSAIDs, including carprofen, in the cat is
longer
than in the dog and the therapeutic index is narrower. In the absence
of
specific data use in the cat is contra-indicated.
Do not use in dogs suffering from cardiac, hepatic or renal disease,
where there is a possibility of gastro-intestinal ulceration or
bleeding, or
where there is evidence of blood dyscrasia or hypersensitivity to the
product. As with other NSAIDs there is a risk of rare idiosyncratic
renal
or hepatic adverse events.
Do not administer other NSAIDs concurrently or within 24 hours of each
other. Some NSAIDs may be highly bound to plasma proteins and
compete with other highly bound drugs, which can lead to toxic
effects.
Revised: April 2020
AN:01995/2019
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
i) Special precautions for use in animals
Use in dogs less than 6 weeks of age, or in aged dogs, may involve
additional risk. If such a use cannot be avoided, such dogs may
require
a reduced dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there
is a potential rise of increased renal toxicity.
Concurrent
administration
of
potential
nephrotoxic
drugs
should
be
avoided.
NSAID’s can cause inhibition o